Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Explore how safety teams manage ICSR validity, day zero, MedDRA coding, seriousness assessment, E2B(R3) reporting, follow-up, and duplicate cases. This guide also explains reporting timelines, inspection evidence, and the controls needed for reliable pharmacovigilance compliance.